This past year the focus has remained on non-invasive tests, and more speci
fically the antigen stool test for which a number of studies have been publ
ished, validating its use for screening as well as for post-therapy follow-
up. The possibilities offered by antibody testing have been further explore
d. A new antibody test in urine has emerged while use of the urea breath te
st, which is now standardized has been extended to children. Biopsy-based t
ests, especially culture, continue to be of great value for macrolide susce
ptibility testing, but new molecular methods such as a PCR hybridization as
say have also been proposed. Curr Opin Gastroenterol 16 (suppl 1):S5-S10 (C
) 2000 Lippincott Williams & Wilkins.